Literature DB >> 11496152

Intermuscular coherence in Parkinson's disease: relationship to bradykinesia.

P Brown1, J Marsden, L Defebvre, F Cassim, P Mazzone, A Oliviero, M G Altibrandi, V Di Lazzaro, P Limousin-Dowsey, V Fraix, P Odin, P Pollak.   

Abstract

We hypothesised that bradykinesia may be partly due to the failure of the corticomuscular system to engage in high frequency oscillatory activity in Parkinson's disease (PD). In healthy subjects such oscillations are evident in coherence between active muscles at 15--30 Hz. We therefore investigated the effects of therapeutic stimulation of the basal ganglia on this coherence and related it to changes in bradykinesia in the contralateral arm. Increases in coherence at 15--30 Hz and improvements in bradykinesia upon stimulation were correlated (r = 0.564, p < 0.001). This suggests that the basal ganglia modulate oscillatory activity in the corticomuscular system and that impairment of the motor system's ability to engage in synchronised oscillations at high frequency may contribute to bradykinesia in PD.

Entities:  

Mesh:

Year:  2001        PMID: 11496152     DOI: 10.1097/00001756-200108080-00057

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  10 in total

1.  Modulation of corticomuscular coherence by peripheral stimuli.

Authors:  Verity M McClelland; Zoran Cvetkovic; Kerry R Mills
Journal:  Exp Brain Res       Date:  2012-04-24       Impact factor: 1.972

Review 2.  Functional brain networks and abnormal connectivity in the movement disorders.

Authors:  Kathleen L Poston; David Eidelberg
Journal:  Neuroimage       Date:  2011-12-21       Impact factor: 6.556

3.  Motor-cortical oscillations in early stages of Parkinson's disease.

Authors:  B Pollok; V Krause; W Martsch; C Wach; A Schnitzler; M Südmeyer
Journal:  J Physiol       Date:  2012-04-30       Impact factor: 5.182

4.  Time and frequency domain methods for quantifying common modulation of motor unit firing patterns.

Authors:  Lance J Myers; Zeynep Erim; Madeleine M Lowery
Journal:  J Neuroeng Rehabil       Date:  2004-10-14       Impact factor: 4.262

5.  Power spectral density analysis of physiological, rest and action tremor in Parkinson's disease patients treated with deep brain stimulation.

Authors:  Tjitske Heida; Eva Christine Wentink; Enrico Marani
Journal:  J Neuroeng Rehabil       Date:  2013-07-08       Impact factor: 4.262

Review 6.  Deep Brain Stimulation and L-DOPA Therapy: Concepts of Action and Clinical Applications in Parkinson's Disease.

Authors:  Muthuraman Muthuraman; Nabin Koirala; Dumitru Ciolac; Bogdan Pintea; Martin Glaser; Stanislav Groppa; Gertrúd Tamás; Sergiu Groppa
Journal:  Front Neurol       Date:  2018-08-27       Impact factor: 4.003

7.  Differential Effects of Pathological Beta Burst Dynamics Between Parkinson's Disease Phenotypes Across Different Movements.

Authors:  Raumin S Neuville; Matthew N Petrucci; Kevin B Wilkins; Ross W Anderson; Shannon L Hoffman; Jordan E Parker; Anca Velisar; Helen M Bronte-Stewart
Journal:  Front Neurosci       Date:  2021-11-11       Impact factor: 5.152

8.  Human subthalamic nucleus in movement error detection and its evaluation during visuomotor adaptation.

Authors:  Huiling Tan; Baltazar Zavala; Alek Pogosyan; Keyoumars Ashkan; Ludvic Zrinzo; Thomas Foltynie; Patricia Limousin; Peter Brown
Journal:  J Neurosci       Date:  2014-12-10       Impact factor: 6.167

9.  Cortico-muscular coupling and motor performance are modulated by 20 Hz transcranial alternating current stimulation (tACS) in Parkinson's disease.

Authors:  Vanessa Krause; Claudia Wach; Martin Südmeyer; Stefano Ferrea; Alfons Schnitzler; Bettina Pollok
Journal:  Front Hum Neurosci       Date:  2014-01-16       Impact factor: 3.169

10.  Detecting a Cortical Fingerprint of Parkinson's Disease for Closed-Loop Neuromodulation.

Authors:  Kevin Kern; Georgios Naros; Christoph Braun; Daniel Weiss; Alireza Gharabaghi
Journal:  Front Neurosci       Date:  2016-03-30       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.